| [1] |
Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming(seventh) edition of the TNM classification of malignant tumours[J]. J Thorac Oncol, 2007, 2: 70 6-14.
|
| [2] |
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
|
| [3] |
Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data[J]. Lancet Oncol, 2007, 8(9): 784-96.
|
| [4] |
Pearson JC, Lemons D, McGinnis W. Modulating Hox gene functions during animal body patterning[J]. Nat Rev Genet, 2005, 6( 12): 893-904.
|
| [5] |
Shah N, Sukumar S. The Hox genes and their roles in oncogenesis[J]. Nat Rev Cancer, 2010, 10(5): 361-71.
|
| [6] |
Gorski DH, Walsh K. The role of homeobox genes in vascular remodeling and angiogenesis[J]. Circ Res, 2000, 87(10): 865-72.
|
| [7] |
Cillo C, Cantile M, Faiella A, et al. Homeobox genes in normal and malignant cells[J]. J Cell Physiol, 2001, 188(2): 161-9.
|
| [8] |
Ford HL. Homeobox genes: a link between development, cell cycle, and cancer?[J]. Cell Biol Int, 1998, 22(6): 397-400.
|
| [9] |
Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence?[J]. Nat Rev Cancer, 2002, 2(10): 777-85.
|
| [10] |
Rao MK, Maiti S, Ananthaswamy HN, et al. A highly active homeobox gene promoter regulated by Ets and Sp1 family members in normal granulosa cells and diverse tumor cell types[J]. J Biol Chem, 2002, 277(29): 26036-45.
|
| [11] |
Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours[J]. Nature, 2000, 405(6789): 974-8.
|
| [12] |
Liu XH, Lu KH, Wang KM, et al. MicroRNA-196a promotes nonsmall cell lung cancer cell proliferation and invasion through targeting HOXA5[J]. BMC Cancer, 2012, 12: 348.
|
| [13] |
Rauch T, Wang Z, Zhang X, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarraybased methylated CpG island recovery assay[J]. Proc Natl Acad Sci U S A, 2007, 104(13): 5527-32.
|
| [14] |
Zhai Y, Kuick R, Nan B, et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion[J]. Cancer Res, 20 07, 67(21): 10163-72.
|
| [15] |
Wang Z, Dahiya S, Provencher H, et al. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer[J]. Clin Cancer Res, 2007, 13(21): 6327-34.
|
| [16] |
Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen[J]. Cancer Cell, 2004, 5(6): 607-16.
|
| [17] |
Jerevall PL, Brommesson S, Strand C, et al. Exploring the twogene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome[J]. Breast Cancer Res Treat, 2008, 107(2): 225-34.
|
| [18] |
Liao WT, Jiang D, Yuan J, et al. HOXB7 as a prognostic factor and mediator of colorectal cancer progression[J]. Clin Cancer Res, 20 11, 17(11): 3569-78.
|
| [19] |
Wu X, Chen H, Parker B, et al. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelialmesenchymal transition[J]. Cancer Res, 2006, 66(19): 9527-34.
|
| [20] |
Rubin E, Wu X, Zhu T, et al. A role for the HOXB7 homeodomain protein in DNA repair[J]. Cancer Res, 2007, 67(4): 1527-35.
|
| [21] |
Nguyen Kovochich A, Arensman M, Lay AR, et al. HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma[J]. Cancer, 2013, 119(3): 529-39.
|
下载:
